title: Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.
abstract: OBJECTIVE
  The aim of the present study was to investigate any relationship between serum ubiquitin levels and electroneurographic changes in peripheral nerves for patients with type 2 diabetes.
  
  
  METHODS
  The study involved 34 patients (19 men, 15 women; mean age 46 +/- 13 years) with type 2 diabetes. Serum ubiquitin values were measured by sandwich enzyme-linked immunosorbent assay Measurement of nerve conduction velocity (NCV) was performed on three motor (median, tibial, and peroneal) and three sensory (median, ulnar, and sural) nerves. The value of motor compound muscle action potential (CMAP) was obtained from the sum of median, tibial, and peroneal motor nerve amplitudes, and sensory compound nerve action potential (CNAP) was computed as the sum of median and ulnar sensory nerve amplitudes.
  
  
  RESULTS
  Patients with diabetes were divided into three groups: group 1 (n = 8) had normal electroneurography results, group 2 (n = 8) had slowed NCV, and group 3 (n = 18) had low values of motor CMAP and/or sensory CNAP as well as slowed NCV. Mean ubiquitin level in group 3 (20.4 +/- 2.9 ng/dl) was significantly higher than that in group 1 (11.2 +/- 1.1 ng/dl, t = 11.5, P < 0.0001) and group 2 (13.2 +/- 2.7 ng/dl, t = 5.9, P < 0.0001). Serum ubiquitin levels were inversely correlated with motor CMAP (r = -0.68) and sensory CNAP (r = -0.61) values.
  
  
  CONCLUSIONS
  The results of this study indicate that there could be a relationship between the diminished amplitudes of axons of the peripheral nerve and the increase in serum ubiquitin levels in patients with type 2 diabetes. Further studies are required to confirm this relationship.
authors.affiliation: Department of Endocrinology, Faculty of Medicine, University of Atatürk, Erzurum, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Akarsu
authors.forename: I
authors.initials: I
authors.lastname: Pirim
authors.forename: I
authors.initials: I
authors.lastname: Capoğlu
authors.forename: O
authors.initials: O
authors.lastname: Deniz
authors.forename: G
authors.initials: G
authors.lastname: Akçay
authors.forename: N
authors.initials: N
authors.lastname: Unüvar
mesh_terms: D000200:Action Potentials; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000097:blood / Q000503:physiopathology*; D004568:Electrodiagnosis; D005260:Female; D006801:Humans; D008297:Male; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D009046:Motor Neurons / Q000502:physiology; D018482:Muscle, Skeletal / Q000294:innervation / Q000502:physiology; D009431:Neural Conduction; D009475:Neurons, Afferent / Q000502:physiology; D010543:Peroneal Nerve / Q000503:physiopathology; D013497:Sural Nerve / Q000503:physiopathology; D013979:Tibial Nerve / Q000503:physiopathology; D014452:Ubiquitins / Q000097:blood*; D014459:Ulnar Nerve / Q000503:physiopathology
chemical_list: D014452:Ubiquitins